Summary
According to the updated results from the Swedish Coronary Angiography and Angioplasty Registry [SCAAR], which now contains up to 4 years of follow-up data for more than 60,000 patients, mortality rates in patients with drug-eluting stents are no higher than in those with bare metal stents.
- interventional techniques & devices clinical trials
- © 2007 MD Conference Express
Tools
4-Year Follow-up Shows No Increased Mortality with Drug-Eluting Stents Compared to Bare Metal Stents in over 60,000 Patients
Permalink:
Table of contents
Cited By...
- No citing articles found.